Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Titel:
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Auteur:
Eron, Joseph J Young, Benjamin Cooper, David A Youle, Michael DeJesus, Edwin Andrade-Villanueva, Jaime Workman, Cassy Zajdenverg, Roberto Fätkenheuer, Gerd Berger, Daniel S Kumar, Princy N Rodgers, Anthony J Shaughnessy, Melissa A Walker, Monica L Barnard, Richard JO Miller, Michael D DiNubile, Mark J Nguyen, Bach-Yen Leavitt, Randi Xu, Xia Sklar, Peter